Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva reports Phase III study results of Quartette contraceptive
The Fly on the Wall
Wednesday, October 24, 2012 - 11:44am
tags:
Teva, Quartette, birth control pill, contraceptives
United Therapeutics Falls as FDA Rejects Oral Remodulin
Bloomberg
Wednesday, October 24, 2012 - 11:43am
tags:
FDA, Remodulin, United Therapeutics, PAH
Pfizer lung cancer drug gets conditional EU approval
Reuters
Wednesday, October 24, 2012 - 11:42am
tags:
Pfizer, Europe, non-small cell lung cancer, Xalkori
Italy bans Novartis flu vaccines pending tests
Reuters
Wednesday, October 24, 2012 - 11:41am
tags:
Italy, Novartis, Flu, vaccines
Bristol-Myers results lag as Plavix sales evaporate
Reuters
Wednesday, October 24, 2012 - 11:00am
tags:
Bristol-Myers Squibb, earnings
AstraZeneca may launch cash bid for Amarin, Daily Mail reports
Yahoo/Fly on the Wall
Wednesday, October 24, 2012 - 10:59am
tags:
AstraZeneca, M&A, Amarin
Aegerion's Lomitapide - FDA Approval, Strong Launch, Stock Price Increase Anticipated
Seeking Alpha
Wednesday, October 24, 2012 - 10:58am
tags:
lomitapide, FDA, Aegerion, Homozygous Familial Hypercholesterolemia
Eli Lilly's 3rd quarter profit climbs 7 pct, revenue slides and drugmaker backs 2012 forecast
Yahoo/AP
Wednesday, October 24, 2012 - 10:57am
tags:
Eli Lilly, earnings
Amgen 3rd quarter profit higher, raises 2012 forecast
Reuters
Tuesday, October 23, 2012 - 4:50pm
tags:
Amgen, earnings
Gilead net drops on higher expenses
Marketwatch
Tuesday, October 23, 2012 - 4:31pm
tags:
Gilead, earnings
Cleveland Biolabs: Gunning For $50 Million In Government Funding
Seeking Alpha
Tuesday, October 23, 2012 - 4:30pm
tags:
Cleveland BioLabs, government funding, entolimod, anti-radiation
Ironwood long-term outlook positive, says Ladenburg
Yahoo/Fly on the Wall
Tuesday, October 23, 2012 - 4:29pm
tags:
Ironwood Pharmaceuticals, linaclotide, AstraZeneca, China
FDA Label Expansion for Abraxane
Yahoo/Zacks
Tuesday, October 23, 2012 - 4:21pm
tags:
FDA, Abraxane, non-small cell lung cancer, Celgene
Could Tofacitinib Save Pfizer?
Seeking Alpha
Tuesday, October 23, 2012 - 4:20pm
tags:
tofacitinib, Pfizer, JNJ, Eli Lilly, rheumatoid arthritis
3 Diabetes Phase 3 Wins
Motley Fool
Tuesday, October 23, 2012 - 4:19pm
tags:
Merck, Sanofi, Eli Lilly, diabetes, AstraZeneca, Bristol-Myers Squibb, dulaglutide, Amylin
Merck Third Quarter Earnings Preview
Investopedia.com
Tuesday, October 23, 2012 - 11:35am
tags:
Merck, earnings
How GlaxoSmithKline Has Fared During 2012
Motley Fool
Tuesday, October 23, 2012 - 11:31am
tags:
GSK
FDA approves Eisai's drug to treat epileptic seizures
Yahoo/Reuters
Tuesday, October 23, 2012 - 9:19am
tags:
FDA, Eisai, epilepsy, seizures, Fycompa
Roche continues to restructure diabetes unit
Indianapolis Business Journal, IN
Tuesday, October 23, 2012 - 9:17am
tags:
Roche, restructuring, diabetes, layoffs
Synergy Pharmaceuticals: Monday's Pipeline News Strengthens Company At Its Core
Seeking Alpha
Tuesday, October 23, 2012 - 9:15am
tags:
Synergy Pharmaceuticals, SP-333, ulcerative colitis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.